Search results
18 kwi 2024 · The response to treatment is measured in 2 ways: (1) improvement or resolution of the clinical presentation of arrhythmias, heart block, or HF and (2) reduction in the degree of active granulomatous inflammation in the myocardium.
16 mar 2023 · A review of cardiac sarcoidosis (CS), a rare inflammatory disease of the heart that can cause arrhythmias, heart failure, and sudden death. Learn about the clinical phenotypes, diagnostic criteria, treatment options, and outcome data of CS.
26 cze 2024 · The multi-disciplinary team based approach to the diagnosis and treatment of cardiac sarcoidosis. CMR, cardiac magnetic resonance; CRT, cardiac resynchronization therapy; ECG, electrocardiogram; FDG-PET, fluorodeoxyglucose positron emission tomography; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ...
The diagnosis of cardiac involvement in sarcoidosis has important clinical and prognostic ramifications, including an increased risk of heart failure, ventricular arrhythmias (VAs) and sudden death. Optimal management strategies of patients with CS are evolving as the evidence base expands.
22 kwi 2024 · Treatment. In general, if the patient is symptomatic, immunosuppression should be initiated in those with definite and highly probable CS. For the probable group, there should be careful discussion with the individual about the risks versus benefits of treatment.
24 lut 2015 · Treatment for cardiac sarcoidosis usually involves immunosuppressive therapy, particularly corticosteroids. Additional therapy might be required, depending on the clinical presentation,...
JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis 6.1.1. Criteria for cardiac involvement. To diagnose cardiac sarcoidosis, cardiac findings should be evaluated using major criteria and minor criteria. The presence of the clinical conclusions satisfying either of the following strongly suggests the presence of cardiac ...
